Growth Inhibition and Induction of Apoptosis in Mcf-7 Breast Cancer Cells by Oridonin Nanosuspension
Fei-Fei Feng,Dian-Rui Zhang,Ke-Li Tian,Hai-Yan Lou,Xiao-Li Qi,Yan-Cai Wang,Cun-Xian Duan,Le-Jiao Jia,Fei-Hu Wang,Yue Liu,Qiang Zhang
DOI: https://doi.org/10.3109/10717544.2010.536271
IF: 6.819
2010-01-01
Drug Delivery
Abstract:The mechanism for anti-tumor activity of oridonin (ORI) nanosuspension, prepared by the high pressure homogenization method, was studied using MCF-7 human breast carcinoma cells in vitro. MTT assay, observation of morphologic changes, flow cytometric analysis, and western blot analysis indicated that ORI nanosuspension could significantly intensify the in vitro anti-tumor activity to MCF-7 cells, as compared with ORI solution. Furthermore, ORI nanosuspension induced G(2)/M stage proliferation arrest and apoptosis in MCF-7 cells depending on its concentration. In addition, western blot analysis indicated that the pro-caspase-3 protein was not cleaved into the activated form and the expression of anti-apoptotic Bcl-2 protein decreased, on the contrary, the expression of pro-apoptotic Bax protein increased in a dose-dependent manner in ORI nanosuspension-treated cells. These observations indicated that the anti-tumor activity of ORI nanosuspension was intensified by cell-cycle arrest and apoptosis induction.